Clinical Reasoning: A 27-year-old man with rapidly progressive coma. 2015

Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
From the California Pacific Medical Center, San Francisco.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003128 Coma A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION. Comatose,Pseudocoma,Comas,Pseudocomas
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal
D022124 Hyperammonemia Elevated level of AMMONIA in the blood. It is a sign of defective CATABOLISM of AMINO ACIDS or ammonia to UREA.
D038524 Diffusion Magnetic Resonance Imaging A diagnostic technique that incorporates the measurement of molecular diffusion (such as water or metabolites) for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient (ADC) with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment. Magnetic Resonance Imaging, Diffusion,Diffusion MRI,Diffusion Weighted MRI,Diffusion MRIs,MRI, Diffusion Weighted

Related Publications

Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
March 2016, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
October 2017, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
April 2020, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
July 2021, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
September 2017, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
June 2014, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
February 2013, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
May 2017, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
June 2019, Neurology,
Jonathan M Wong, and Mekhala Chandra, and Rachael VanDeBogart, and Brandon Lu, and Alan H Yee
July 2015, Neurology,
Copied contents to your clipboard!